Header2

Cancer and the Heart, 2/e

ISBN: 978-1-60795-040-0

Ewer_-_web

Price
$130.00

 

 

Pub Date: February 2013
ISBN:
9781607950400
Previous Edition ISBN: 1550092685
Format: Casebound
Subject Area: Oncology/Cardiology
Pages: 550

Images: 134 images and 68 tables

About the Book

 

The book begins with the basic science behind the medical applications of the knowledge: cardiovascular biology, pathways, and their relationship to cancer treatment and principles of chemotherapy and immunotherapy.

 

The second section consists of an overview and classification of anti-cancer drugs and a look at their cardiotoxicity. The third section looks at cardiac imaging in the cancer patient, including cardiac ultrasound, Doppler imaging, nuclear imaging, magnetic resonance imaging, and computed tomography in the cancer patient. In section four, management of cardiac disease in the cancer patient is discussed, including cardiac rhythm disturbances and heart failure. Cardiac emergencies and interventions are described as is preoperative assessment of the cancer patient for non-cardiovascular surgery. The final section includes a range of topics such as the pericardium, cardiovascular effects of endocrine treatments, primary cardiac tumors and malignancies of the myocardium and pericardium. Cardiac monitoring during clinical trials and pulmonary concerns are also addressed, as are psychosocial, social, economic, and legal issues of the cancer patient with heart disease.

About the Author
Michael S. Ewer, M.D., M.P.H., J.D.,
is Professor of Medicine at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. He received his medical degree from the University of Basel in Switzerland and was a cardiology fellow at Baylor University Medical Center in Dallas, Texas. His clinical and research interests include cardiotoxicity of anthracyclines, trastuzumab cardiotoxicity, and ethical and legal concerns with regard to cancer patients.

Edward T.H. Yeh, M.D., is Professor of Medicine and Chair, Department of Cardiology at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. He received his medical degree from the University of California at Davis, and he was a cardiology fellow at the University of Texas—Houston Health Science Center. His clinical and research interests include the role of inflammation in the development of coronary artery disease; cardiac complications of anti-cancer therapy; stem cell transplant for congestive heart failure; and ubiquitin, ubiquitin-like proteins, and cancer.

Audience:
Primary: oncologists and cardiologists
Secondary: internists, other primary care doctors

Table of Contents:

SECTION 1: BASIC SCIENCE CONSIDERATIONS


Overview

1. Cardiovascular Biology, Pathways, and the Relationship to Cancer Treatment by Thomas Force.

2. Principles of Chemotherapy and Immunotherapy by Scott Lipmann

SECTION II: CARDIOTOXICITY OF ANTI-CANCER TREATMENT

Overview and Classification of Anti-Cancer Drugs

3. Antracycline Cardiotoxicity and the Cardiotoxicity of Related Agents; Type I treatment-related Cardiotoxicity by Michael S. Ewer

4. Trastuzumab Cardiotoxicity by Thomas Suter

5. Cardiotoxicity of Tyrosine-Kinase Inhibitors and Other Type II Agents by Aarif Khakoo

6. Cardiotoxicity of Other anti-cancer therapy by Edward Yeh and Courtney Bickford

7. Effects of Radiation Therapy on the Cardiovascular system by Sarah Darby [Oxford] 8. Cardiac considerations of cancer treatment in infants and children by Stephen Lipschultz

SECTION III: CARDIAC IMAGING IN THE CANCER PATIENT

Overview of Imaging

9. Cardiac ultrasound, Doppler imaging, and related techniques in the cancer patient by Juan Carlos Plana and Jose Banchs

10. Nuclear Imaging, Magnetic resonance imaging, and computed tomography in the cancer patient by Iyad N. Daher and Ellie Mouhayer

SECTION IV: MANAGEMENT OF CARDIAC DISEASE IN THE CANCER PATIENT

Overview

11. Disturbances of Cardiac Rhythm in the cancer patient by Steven Ewer

12. Heart failure in the cancer patient by Daniel Lenihan

13. Cardiac interventions in the cancer patient by Cesar Iliescu

14. Cardiac emergencies in the cancer patient by Carmen Escalante

15. Preoperative assessment of the cancer patient for non-cardiovascular surgery by Marc Rozner

SECTION V: MISCELLANEOUS TOPICS

Overview

16. The pericardium in the cancer patient by Steven M. Ewer

17. Cardiovascular effects of endocrine treatment of cancer by Michael Ewer and Stephen Glück

18. Primary cardiac tumors and malignancyof the myocardium and pericardium by Michael J. Reardon

19. Cardiac monitoring during clinical trials by Sandra Swain and Edith Perez

20. Social, Economic, and legal issues of heart disease in the Cancer patient by Willima Windslade

21. Pulmonary considerations with regard to the cancer patient by Vicki Shannon

22. Psychosocial considerations of heart disease in the cancer patient by Anecita Fadol